Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

IGF-1 lr3

Long R3 IGF-1, LR3-IGF-1, Insulin-like Growth Factor-1 Long Arg3

Quick Stats
Studies 41
Trials 0
Score 3
2025 pubmed

Revolutionary decellularized Alstroemeria stem-based nerve conduit integrated with GelMA and controlled IGF-1 LR3 release for enhanced rat sciatic nerve regeneration.

Yavuz. Ersin E; Sağır. Melih S MS; Ercan. Alp A; Erginer. Merve M; Barlas. Fırat B FB; Sakarya. Deniz D; Kılıç. Şima Ş; Ölçeroğlu. Bilge B; Yardibi. Hasret H; Kalaycılar. İsmail B İB; Demiröz. Anıl A

Key Findings

  • The plant‑based conduit with IGF‑1 LR3 supported strong axonal regeneration in rats
  • Its performance was comparable to autologous nerve grafts
  • No systemic toxicity was observed with the controlled IGF‑1 LR3 release

Practical Outcomes

  • IGF‑1 LR3 shows promise for helping nerve repair when delivered locally, but the study is in rats and uses a specialized implant. For DIY enthusiasts, it suggests IGF‑1 LR3 might aid nerve healing, yet safe human protocols, dosing, and delivery methods still need solid research.

Summary

A new nerve tube made from a plant stem and a gel was tested in rats with a small sciatic nerve gap. It slowly released the peptide IGF‑1 LR3, which helped nerves grow back as well as the current gold‑standard nerve graft, and it didn’t cause any obvious side effects.

Abstract

Peripheral nerve injuries lead to significant functional deficits, with no treatment achieving complete recovery. Autologous nerve grafting remains the gold standard, but it is limited by donor site morbidity. Artificial nerve conduits have been developed but have not matched the outcomes of autologous grafts. This study introduces the first-ever decellularized plant-based nerve conduit, fabricated from Alstroemeria stem material, integrated with GelMA, and featuring controlled release of Insulin-like Growth Factor Long Arginine 3 (IGF-1 LR3) for enhanced axonal regeneration. Thirty rats were assigned to six experimental groups (n = 5) and underwent a 1 cm sciatic nerve defect. Regeneration was assessed via gait analysis, electrophysiology, histology, and immunohistochemistry, comparing the decellularized conduit to autologous grafts and commercial conduits. The IGF-1 LR3-controlled releasing decellularized conduit significantly improved axonal regeneration and showed comparable performance to autologous nerve grafts, without inducing systemic toxicity. This novel conduit demonstrates the potential of plant-based biomaterials for effective peripheral nerve repair.

Study Information

Provider

pubmed

Year

2025

Date

2025-09-25T00:00:00.000Z

DOI

10.1016/j.ijbiomac.2025.147888

References

86